Hourglass Capital, LLC Bristol Myers Squibb CO Transaction History
Hourglass Capital, LLC
- $332 Million
- Q1 2024
A detailed history of Hourglass Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hourglass Capital, LLC holds 4,307 shares of BMY stock, worth $183,779. This represents 0.07% of its overall portfolio holdings.
Number of Shares
4,307
Previous 4,213
2.23%
Holding current value
$183,779
Previous $216,000
7.87%
% of portfolio
0.07%
Previous 0.07%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,499Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.94 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.94 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.91 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.79 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$3 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $90.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...